Glenmede Trust’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $453K | Sell |
13,098
-21
| -0.2% | -$726 | ﹤0.01% | 944 |
|
|
2024
Q4 | $360K | Sell |
13,119
-3,196
| -20% | -$87.7K | ﹤0.01% | 1035 |
|
|
2024
Q3 | $415K | Buy |
16,315
+187
| +1% | +$4.76K | ﹤0.01% | 997 |
|
|
2024
Q2 | $409K | Buy |
16,128
+194
| +1% | +$4.91K | ﹤0.01% | 975 |
|
|
2024
Q1 | $493K | Buy |
15,934
+929
| +6% | +$28.7K | ﹤0.01% | 930 |
|
|
2023
Q4 | $606K | Sell |
15,005
-1,489
| -9% | -$60.1K | ﹤0.01% | 838 |
|
|
2023
Q3 | $435K | Sell |
16,494
-3,440
| -17% | -$90.7K | ﹤0.01% | 884 |
|
|
2023
Q2 | $331K | Hold |
19,934
| – | – | ﹤0.01% | 956 |
|
|
2023
Q1 | $331K | Buy |
+19,934
| New | +$331K | ﹤0.01% | 961 |
|
|
2020
Q2 | – | Sell |
-41
| Closed | -$1K | – | 2443 |
|
|
2020
Q1 | $1K | Hold |
41
| – | – | ﹤0.01% | 2915 |
|
|
2019
Q4 | $1K | Buy |
+41
| New | +$1K | ﹤0.01% | 2915 |
|